Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002544769 | SCV000814645 | likely benign | Dyskeratosis congenita, autosomal dominant 2; Idiopathic Pulmonary Fibrosis | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004559353 | SCV002648765 | likely benign | Dyskeratosis congenita | 2019-09-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Neuberg Centre For Genomic Medicine, |
RCV003388593 | SCV004100591 | uncertain significance | Dyskeratosis congenita, autosomal dominant 2 | criteria provided, single submitter | clinical testing | The missense variant p.R185W in TERT (NM_198253.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. It has been submitted to ClinVar as Uncertain Significance. There is a moderate physicochemical difference between arginine and tryptophan. The p.R185W missense variant is predicted to be tolerated by both SIFT or PolyPhen2. The nucleotide c.553 in TERT is not conserved according to a GERP++ and PhyloP analysis of 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. |